Retrospective molecular and phenotypic analysis of poliovirus vaccine strains isolated in Greece

Clinical Microbiology and Infection

Volumn 17, Issue 10, 2011, Pages 1554-1562

  Pliaka, V ^a   Filliponi, M E ^a   Kyriakopoulou, Z ^a   Ruether, I G A ^a   Tsakogiannis, D ^a   Gartzonika, C ^b   Levidiotou Stefanou, S ^b   Markoulatos, P ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Greece; Immunity; Mutations; Neurovirulence; Oral poliovirus vaccine isolates; Polioviruses; Recombination

Indexed keywords

ANTISERUM; NEUTRALIZING ANTIBODY; ORAL POLIOMYELITIS VACCINE; VIRUS RNA;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ANTIBODY TITER; ARTICLE; CHILD; GREECE; GROUPS BY AGE; GROWTH CURVE; HUMAN; IMMUNITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLIOMYELITIS VIRUS; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; TEMPERATURE SENSITIVITY; VIROGENESIS; VIRUS GENOME; VIRUS ISOLATION; VIRUS MUTATION; VIRUS NEUTRALIZATION; VIRUS RECOMBINANT; VIRUS RECOMBINATION; VIRUS STRAIN;

HUMAN POLIOVIRUS 3; POLIOVIRUS;

EID: 80053087369     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2011.03470.x     Document Type: Article

References (37)

1. Wimmer E, Hellen CUT, Cao X. Genetics of poliovirus. Annu Rev Genet 1993; 27: 353-436.
2. Minor PD. Antigenic structure of picornaviruses. Curr Top Microbiol Immunol 1990; 161: 124-134.
3. Macadam AJ, Pollard SR, Ferguson G et al. The 5′ noncoding region of the type 2 poliovirus vaccine strain contains determinants of attenuation and temperature sensitivity. Virology 1991; 81: 451-458.
4. Bouchard MJ, Lam DH, Racaniello VR. Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine. J Virol 1995; 69: 4972-4978.
5. Guest S, Pilipenko E, Sharma K, Chumakov K, Roos RP. Molecular mechanisms of attenuation of the Sabin strain of poliovirus type 3. J Virol 2004; 78: 11097-11107.
6. Equestre M, Genovese D, Cavalieri F, Fiore L, Santoro R, Perez Bercoff R. Identification of a consistent pattern of mutations in neurovirulent variants derived from the sabin vaccine strain of poliovirus type 2. J Virol 1991; 65: 2707-2710.
7. Otelea D, Guillot S, Furione M et al. Genomic modifications in naturally occurring neurovirulent revertants of Sabin 1 polioviruses. Dev Biol Stand 1993; 78: 33-38.
8. Gnanashanmugam D, Falkovitz-Halpern MS, Dodge A et al. Shedding and reversion of oral polio vaccine type 3 in Mexican vaccinees: comparison of mutant analysis by PCR and enzyme cleavage to a real-time PCR assay. J Clin Microbiol 2007; 45: 2419-2425.
9. Cherkasova EA, Korotkova EA, Yakovenko ML et al. Long-term circulation of vaccine-derived poliovirus that causes paralytic disease. J Virol 2002; 76: 6791-6799.
10. Kapusinszky B, Molnár Z, Szomor KN, Berencsi G. Molecular characterization of poliovirus isolates from children who contracted vaccine-associated paralytic poliomyelitis (VAPP) following administration of monovalent type 3 oral poliovirus vaccine in the 1960s in Hungary. FEMS Immunol Med Microbiol 2010; 58: 211-217.
11. Yakovenko ML, Cherkasova EA, Rezapkin GV et al. Antigenic evolution of vaccine-derived polioviruses: changes in individual epitopes and relative stability of the overall immunological properties. J Virol 2006; 80: 2641-2653.
12. Frantzidou-Adamopoulou F. Poliomyelitis cases in Northern Greece 1976-1990. Eur J Epidemiol 1992; 8: 112-113.
13. Pliaka V, Dedepsidis E, Kyriakopoulou Z et al. Growth kinetic analysis of bi-recombinant poliovirus vaccine strains. Virus Genes 2010; 40: 200-211.
14. Georgopoulou A, Markoulatos P, Spyrou N, Vamvakopoulos NC. Improved genotyping vaccine and wild-type poliovirus strains by restriction fragment length polymorphism analysis: clinical diagnostic implications. J Clin Microbiol 2000; 38: 4337-4342.
15. Balanant J, Guillot S, Candrea A, Delpeyroux F, Crainic R. The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay. Virology 1991; 184: 645-654.
16. Oberste MS, Maher K, Flemister MR, Marchetti G, Kilpatrick DR, Pallansch MA. Comparison of classic and molecular approaches for the identification of untypeable enteroviruses. J Clin Microbiol 2000; 38: 1170-1174.
17. Dedepsidis E, Karakasiliotis I, Paximadi E, Kyriakopoulou Z, Komiotis D, Markoulatos P. Detection of unusual mutation within the VP1 region of different re-isolates of poliovirus Sabin vaccine. Virus Genes 2006; 33: 183-191.
18. Paximadi E, Karakasiliotis I, Mamuris Z, Stathopoulos C, Krikelis V, Markoulatos P. Genomic analysis of recombinant sabin clinical isolates. Virus Genes 2006; 32: 203-210.
19. Pliaka V, Dedepsidis E, Kyriakopoulou Z et al. A new RT-PCR assay for the identification of the predominant recombination types in 2C and 3D genomic regions of vaccine-derived poliovirus strains. Mol Cell Probes 2010; 24: 115-123.
20. Casas I, Powell L, Klapper PE, Cleator GM. New method for the extraction of viral RNA and DNA from cerebrospinal fluid for use in the polymerase chain reaction assay. J Virol Methods 1995; 53: 25-36.
21. Pliaka V, Ruether IG, Kyriakopoulou Z et al. A seroprevalence study of poliovirus antibody against a collection of recombinant and non-recombinant poliovirus vaccine strains in the population of southern Greece. Clin Microbiol Infect 2010; 16:1672-1675.
22. Pliaka V, Dedepsidis E, Kyriakopoulou Z, Papadopoulou I, Levidiotou S, Markoulatos P. Use of mutational pattern in 5′-NCR and VP1 regions of polioviruses for molecular diagnosis. Mol Cell Probes 2007; 21: 267-275.
23. Harber J, Bernhardt G, Lu HH, Sgro JY, Wimmer E. Canyon rim residues, including antigenic determinants, modulate serotype specific binding of polioviruses to mutants of the poliovirus receptor. Virology 1995; 214: 559-570.
24. Colston EM, Racianello VR. Soluble receptor-resistant poliovirus mutants identify surface and internal capsid residues that control interaction with the cell receptor. EMBO J 1994; 13: 5855-5862.
25. Mento SJ, Weeks-Levy C, Tatem JM, Gorgacz EJ, Waterfield WF. Significance of a newly identified attenuating mutation in Sabin 3 oral poliovirus vaccine. Dev Biol Stand 1993; 78: 93-100.
26. Agol VI. Vaccine-derived polioviruses. Biologicals 2006; 34: 103-108.
27. Cello J, Toyoda H, Dejesus N, Dobrikova EY, Gromeier M, Wimmer E. Growth phenotypes and biosafety profiles in poliovirus-receptor transgenic mice of recombinant oncolytic polio/human rhinoviruses. J Med Virol 2008; 80: 352-359.
28. Egger D, Bienz K. Recombination of poliovirus RNA proceeds in mixed replication complexes originating from distinct replication start sites. J Virol 2002; 76: 10960-10971.
29. Frantzidou F, Diza E, Halkia D, Antoniadis A. A seroprevalence study of poliovirus antibody in the population of northern Greece. Clin Microbiol Infect 2005; 11: 68-71.
30. Mastroeni I, Patii AM, Fabrizi A et al. Immunity status against poliomyelitis in persons 13-14 years old living in Rome. Vaccine 1997; 15: 745-750.
31. Mulders MN, Reimerink JH, Stenvik M et al. A Sabin vaccine-derived field isolate of poliovirus type 1 displaying aberrant phenotypic and genetic features, including a deletion in antigenic site 1. J Gen Virol 1999; 80: 907-916.
32. Blomqvist S, Skytta A, Roivainen M, Hovi T. Rapid detection of human rhinoviruses in nasopharyngeal aspirates by a microwell reverse transcription-PCR-hybridization assay. J Clin Microbiol 1999; 37: 2813-2816.
33. Dedepsidis E, Pliaka V, Kyriakopoulou Z et al. Complete genomic characterization of an intertypic Sabin3/Sabin2 capsid recombinant. FEMS Immunol Med Microbiol 2008; 52: 343-351.
34. Dedepsidis E, Kyriakopoulou Z, Pliaka V et al. Retrospective characterization of a vaccine-derived poliovirus type 1 isolate from sewage in Greece. Appl Environ Microbiol 2007; 73: 6697-6704.
35. Mulders MN, Lipskaya GY, van der Avoort HG, Koopmans MP, Kew OM, van Loom AM. Molecular epidemiology of wild poliovirus 1 in Europe, the Middle East, and the Indian subcontinent. J Infect Dis 1995; 171: 1399-1405.
36. Caro V, Guillot S, Candrea A, Delpeyroux F, Crainic R. Molecular strategy of 'serotyping' of human enterovirus. J Gen Virol 2001; 82: 79-91.
37. Guillot S, Caro V, Cuervo N et al. Natural genetic exchanges between vaccine and wild poliovirus strains in humans. J Virol 2000; 74: 8434-8443.